Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Intranasal Breast Milk

Research Leaders

6 sponsors active, led by Assiut University

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (1)
Early Phase 1 (3)
Phase 1 (1)
Phase 3 (1)

Trial Status

Recruiting3
Unknown2
Completed2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Intranasal Breast Milk2
  • Infusion Of Autologous Cord Blood1
  • Sulfur Hexafluoride1
  • Magnetic Resonant Imagingcranial Ultrasound1
  • Brain Contrast Enhanced Ultrasound Brain Ultrasound Elastography1

Active Sponsors

  • Assiut University3
  • Semmelweis University2
  • University Hospital, Bordeaux1
  • Turku University Hospital1
  • Varsinais-Suomen hyvinvointialue1

Top Investigators

Related Conditions

  • Perinatal Asphyxia2
  • Neonatal Encephalopathy2
  • Hypoxic Ischemic Encephalopathy Of Newborn1
  • Neonatal Stroke1
  • Neonatal Encephalopathy Unspecified1

Activity Timeline